
Study shows what a pet dog can do to save your child's skin from eczema
A new study suggests that children with a genetic predisposition to eczema may benefit from having a pet dog at home.
Researchers found that early exposure to dogs could have a protective effect against the skin condition, which causes itchy skin.
However, the academics stressed that the study did not examine the impact of dog exposure on existing eczema. They also warned that introducing a dog could worsen symptoms in some children.
Atopic eczema is typically caused by a combination of genetic and environmental factors, but how the two interact is not well understood.
An international team of researchers, including academics from the University of Edinburgh, examined data on 280,000 people to investigate whether those who are genetically more likely to develop eczema might respond differently to environmental factors, such as pet ownership, whether they were breastfed or had siblings.
They found that children with a change in their DNA that increases their chance of developing eczema were less likely to have the condition if they were exposed to a dog in early life.
'We detected an observational association between early-life dog exposure and reduction in prevalence of atopic eczema,' the international team of researchers wrote in the journal Allergy.
Researchers performed an initial analysis on more than 25,000 people, which suggested there could be an interaction between seven environmental factors – antibiotic use, cat ownership, dog ownership, breastfeeding, elder sibling, smoking and washing practices – and at least one genetic variant for eczema.
Secondary analysis on data on almost 255,000 people suggested that there was a 'nominally significant' link between having a dog in early years, and a variation in genetic code located near a protein involved in immune cell function and inflammation, called interleukin-7 receptor (IL-7R).
Experts said that the findings suggest that the IL-7R protein may provide a potential target for future treatment or prevention of eczema.
Professor Sara Brown, from the University of Edinburgh's Institute of Genetics and Cancer, said: 'The most difficult questions I'm asked by parents in clinic are about why their child has eczema, and how they can help.
'We know that genetic make-up affects a child's risk of developing eczema, and previous studies have shown that owning a pet dog may be protective, but this is the first study to show how this may occur at a molecular level.
'More work is needed, but our findings mean we have a chance to intervene in the rise of allergic disease, to protect future generations.'
Dr Marie Standl, from Helmholtz Munich, said 'This study sheds light on why some children develop eczema in response to environmental exposures while others don't.
'Not every preventive measure works for everyone, and that's precisely why gene-environment studies are crucial.
'They help us move toward more personalised, effective prevention strategies.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
26 minutes ago
- Daily Mail
Walking wounded told not to go to A&E as Labour plots £450m shake-up to end 'corridor care' in hospitals
The walking wounded will be told to avoid visiting A&E amid a major NHS shake-up revealed today which aims to divert them to a series of new urgent care centres. The Government has come up with the plan in an attempt to ensure hundreds of thousands fewer patients face long A&E waits in a bid to end 'corridor care'. Almost £450million will be put into creating better care and more facilities with an emphasis on caring for people closer to their homes, according to officials. Some 40 new same day emergency care and urgent treatment centres will also be established across England to treat and discharge patients the same day. The centres will deal with all but the most serious cases, with millions of patients urged to visit them instead of A&E to avoid unnecessary hospital admissions. Units located next to A&Es are likely to be within the network, focusing on patients with issues that are not life threatening who can be discharged the same day. Deteriorations in chronic illnesses and wound infections are among the issues that medics will be able to deal with at the new centres, reported The Telegraph. It is hoped the plan will result in 800,000 fewer patients each year waiting more than four hours at A&E and free up space for genuine emergencies to be dealt with. There are also proposals for 15 mental health crisis assessment centres, which are designed to ensure mentally ill people do not have to wait in A&E for hours for care. It comes after the NHS experienced a crisis over winter, with patients waiting hours for beds and regularly being treated in corridors - so-called corridor care. A&E waiting time targets have not been met for more than a decade, while the 18-minute target for category 2 ambulance calls - such as those suffering stroke, heart attack, sepsis or major trauma - has never been hit outside the pandemic. The new Urgent and Emergency Care Plan for England says more needs to be done to drive down long waits, cut delayed discharges and improve care for patients. An earlier version of the document said NHS trusts would need to show how, by this winter, systems will 'improve flow through hospitals, with a particular focus on patients waiting over 12 hours, and eliminate corridor care'. But the later version does not commit to a timescale for ending corridor care, instead saying systems must 'improve flow through hospitals, with a particular focus on reducing patients waiting over 12 hours and making progress on eliminating corridor care'. Ministers have also set an ambition for a minimum of 78 per cent of patients who attend A&E (up from the current 75 per cent) to be admitted, transferred or discharged within four hours, meaning 'over 800,000 people a month will receive more timely care'. There will also be a focus on seeing more children, according to the Department of Health and NHS England. The Government wants to slash the number of patients waiting more than 12 hours for a hospital bed - or to be discharged from A&E - so this occurs 'less than 10 per cent of the time', according to the new document. Around 1.7million attendances at A&E every year currently exceed this time frame. Further measures in the plan are intended to drive down delayed discharges from hospital, which occur when people are medically fit to leave but care in their homes or community has not yet been put in place. Local performance targets will be set to improve patient discharge times, and 'eliminate internal discharge delays of more than 48 hours in all settings', the plan said. Experts said A&E 'league tables' will be published to drive up performance. Those patients who need an overnight emergency admission will also have their overall stay reduced where appropriate - the average is 'currently nearly a day longer than in 2019'. The plan further sets out how ambulance waiting times for category 2 patients will be cut by more than 14 per cent, from 35 to 30 minutes. A previous target of 18 minutes has been repeatedly missed. In the document, there is an aim to 'eradicate' last winter's lengthy ambulance handover delays by meeting a maximum 45-minute target for patients to be handed over to A&E. This should help 'get 550,000 more ambulances back on the road for patients', it says. According to the document, almost 500 new ambulances will also be rolled out across the country by March 2026. Health Secretary Wes Streeting said: 'No patient should ever be left waiting for hours in hospital corridors or for an ambulance which ought to arrive in minutes. 'We can't fix more than a decade of underinvestment and neglect overnight. 'But through the measures we're setting out today, we will deliver faster and more convenient care for patients in emergencies. 'Far too many patients are ending up in A&E who don't need or want to be there, because there isn't anywhere else available. 'Because patients can't get a GP appointment, which costs the NHS £40, they end up in A&E, which costs around £400 - worse for patients and more expensive for the taxpayer. 'The package of investment and reforms we are announcing today will help the NHS treat more patients in the community, so they don't end up stuck on trolleys in A&E.' Under the plans, paramedics will play a bigger role in the community, with patients given 'more effective treatment at the scene of an accident or in their own homes from ambulance crews'. More patients will also be seen by urgent community response teams in their own homes to try to avoid hospital admission. The NHS is also pledging better use of virtual wards, where patients are monitored by hospital staff from their home, and there are plans to drive up vaccination rates among NHS staff to help protect patients. Royal College of Emergency Medicine president Dr Adrian Boyle said: 'There is some good and some bad - but we wholeheartedly welcome the commitment to publish A&E performance data for each and every hospital and we thank NHS England and the Department of Health for heeding our recommendation. 'In this plan, for possibly the first time, NHS England acknowledges the shameful situation being experienced by patients and clinicians across the country's emergency departments - and that must be commended. 'However, some parts lack ambition - for example accepting that 10 per cent of people will face A&E waits of more than 12 hours, when no patient should. 'Also maintaining the four-hour standard at 78 per cent when the stated aim is that 95 per cent of patients should move through the emergency department within this time - something which hasn't happened for a decade.' He said there were also concerns about how the maximum 45-minute ambulance handover will be achieved 'without exposing patients to risk and increasing overcrowding in our departments'. Association of Ambulance Chief Executives managing director Anna Parry said: 'We are particularly heartened to see the plan's emphasis on the reduction and improved management of hospital handover delays. 'Handover delays have the greatest detrimental impact on ambulance resources and create unnecessary delays and additional harm for thousands of patients each year. 'The elimination of corridor care and the focus on reducing 12-hour waits at emergency departments is also welcomed.' The Liberal Democrats claimed the Government had listened to their calls to end corridor care, but called on ministers to follow through on their promises. Lib Dem health spokesperson Helen Morgan MP said: 'Patients have heard these kinds of promises before only to be led up the garden path. 'We can't bear any more of the shameful neglect and failed delivery that we saw for a decade under the Conservatives. 'It's good to see ministers finally listen to Liberal Democrat demands to end corridor care but the misery in our A&Es will only be prolonged if they continue to move at a snail's pace on social care. 'Until they grasp this nettle, millions are at risk of dangerously long waits in A&E. They must see sense and conclude their review into social care by the end of this year.'


Daily Mail
27 minutes ago
- Daily Mail
Natasha Hamilton reveals secret cancer battle in emotional Good Morning Britain interview - after mistaking warning signs for mosquito bite
Natasha Hamilton opened up about her secret skin cancer battle in an emotional Good Morning Britain interview on Friday. The former Atomic Kitten singer, 42, gave fans a health update as she spoke about her diagnosis of Basal-cell carcinoma -which she received last year - with hosts Kate Garraway, 58, and Robert Rinder, 47. Basal cell carcinoma (BCC) is a type of non-melanoma skin cancer. Non-melanoma means it does not involve skin pigment cells. Kate pointed out: 'I was saying thankfully because we want to establish that you are now fine. You're cancer free and all is good, but you're a living health warning in a way.' Natasha said: 'I am. now I have to be really vigilant, I have to check my skin all the time. 'Since then I've had a few things appear where I've had to go back to the dermatologist, they're on the "watch list". From A-list scandals and red carpet mishaps to exclusive pictures and viral moments, subscribe to the DailyMail's new Showbiz newsletter to stay in the loop. The 42-year-old thought that she had been bitten while on holiday, but then after four weeks, realised that it was something else (pictured) 'This is probably something I am going to have to keep an eye for the rest of my life.' The singer went on to explain how she was diagnosed with cancer. Natasha said: 'So I had been on holiday, I wasn't actually in the sun a lot, my baby was only about five months old and I was breastfeeding. 'One afternoon I had her on my lap, my back was in the sun and I burnt. 'I don't know if it was later that day or the next day, I had an itchy spot on my back, i thought it was a mosquito bite... 'I felt it, I went "oh mosquito bite". 'It wasn't until four weeks later when I was at home and it was itching I was like hang on a minute that seems a bit long for a mosquito bite. 'I asked my hub to have look and he went oh that's not a bite, he took a picture, I looked at it and I went I think I know what that is. 'Originally it had just been a dark freckle. 'I had on my back for many years, it wasn't raised it wasn't a mole. ' 'It was just a freckle.' Kate then asked her about her sunbed use from her Atomic Kitten days, to which Natasha said: 'People of my age will probably feel the same or remember, if you were going on a night out, you used a sunbed cos you wanted that sun kissed look to make yourself feel good, to give you a bit of confidence. 'If I was going to do something like Top of The Pops, or a big TV show, I'd want to look sun kissed, so we would go to the sunbeds. 'There was a sun bed shop facing the hotel that we stayed in all the time in London. 'I used tan accelerators and I can honestly say I don't think that there was ever a time when I went on a sun bed that I didn't burn, looking back now. 'I'm type one skin anyway, I'm not supposed to be in such intense sun.' The star also revealed that her mum has also had her own battle with skin cancer. Natasha explained: 'Two years previous, my mum had been suffering with a patch of dry skin that wouldn't heal. 'I wasn't anything ominous looking, it was a piece of skin. 'I said to her go and see a dermo, I'd done a lot of research previous. 'Initially she was told it was nothing and sent away. 'That was at the doctors, a year later, I saw it and it looked sore and aggravated, I said mum please ask them to refer you to a dermatologist. 'Straight away they said look it is skin cancer. 'She had a lot of cancerous sells burnt off her face, it was very painful for her.' Good Morning Britain airs weekdays from 6:00am on ITV. WHAT IS BASAL CELL CARCINOMA? Basal cell carcinoma (BCC) is a type of non-melanoma skin cancer. Non-melanoma means it does not involve skin pigment cells. BCC makes up more than 80 per cent of all forms of skin cancer in the UK and US. About 5.4 million basal and squamous cell skin cancers are diagnosed each year in the US and around 100,000 in the UK. It is mainly caused by overexposure to UV light from the sun or tanning beds. BCC can occur anywhere on the body but is most common on areas exposed to the sun, such as the face, neck and ears. The following people are most at risk: People with fair skin or hair Those who work outdoors People who use sunbeds Those with a personal history of the condition BCC is usually painless. Early symptoms often only include a scab that bleeds occasionally and does not heal. Some appear as flat, red, scaly marks or have a pearl-like rim. The latter can then erode into a ulcer. Others are lumpy with shiny nodules crossed by blood vessels. Most BCCs can be cured, however, treatment is complex if they are left for a long time. Treatment usually involves removing the cancerous tumour and some of the surrounding skin.


The Independent
29 minutes ago
- The Independent
Statins can reduce sepsis deaths, study suggests
People who are critically ill with sepsis may be more likely to survive if they are given statins, a new study suggests. Researchers wanted to explore whether the cholesterol-busting drugs may bring additional benefits for patients. The new study examined information on sepsis patients who received statins during a stint in intensive care and compared it with patients in a similar situation who did not receive statins. Some 14.3% of 6,000 sepsis patients who were given statins died within 28 days. This is compared with 23.4% of 6,000 patients who did not receive statin therapy. The research team from China said that this equates to a 39% reduced risk of death within a month. The research, based on data from thousands of patients at a hospital in Israel between 2008 and 2019, also found that 7.4% of statin patients died while in the intensive care unit compared with 13.6% of those who did not receive statins. And during their overall hospital stay, some 11.5% of sepsis patients who were given statins died, compared with 19.1% of sepsis patients who did not take statins. However, it appeared that those who were not prescribed statins had a slightly shorter hospital stay compared with those who did receive them – an average of eight days compared with almost 10 days. 'We found that statin users exhibited decreased 28-day all-cause mortality,' the authors wrote in the journal Frontiers in Immunology. Sepsis is a life-threatening reaction to an infection that occurs when the immune system overreacts and starts to damage the body's tissues and organs. In the UK, 245,000 people are affected by sepsis every year. UK sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored' as they called for larger trials to confirm the findings. Statins are known as cholesterol-busting drugs because they can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. But experts said that they also have other benefits, including reducing inflammation and antibacterial effects. The research team called for larger trials to confirm their findings. 'Our large, matched cohort study found that treatment with statins was associated with a 39% lower death rate for critically ill patients with sepsis, when measured over 28 days after hospital admission,' said Dr Caifeng Li, the study's corresponding author and an associate professor at Tianjin Medical University General Hospital in China. 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Commenting on the study, Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. 'Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.'